Company Filing History:
Years Active: 2007
Title: Raphaël Hopfner: Innovator in Cancer Diagnosis and Treatment
Introduction
Raphaël Hopfner is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of medical research, particularly in the area of cancer diagnosis and treatment. His innovative work has led to the development of a patented technology that holds promise for improving patient outcomes.
Latest Patents
Raphaël Hopfner holds a patent for the invention titled "ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer." This invention focuses on a novel ICBP90 (Inverted CCAAT box binding protein 90) and its fragments, as well as polynucleotides that code for these polypeptides. The patent also includes specific antibodies directed against these polypeptides. The invention outlines methods and kits for diagnosing cell proliferation and identifies compounds that can be used as medicine for preventing and/or treating pathologies involving cell proliferation, particularly cancer.
Career Highlights
Raphaël Hopfner is affiliated with the Institut National de la Santé et de la Recherche Médicale, where he conducts his research and development activities. His work is characterized by a strong focus on innovative solutions that address critical health challenges.
Collaborations
Raphaël has collaborated with esteemed colleagues, including Christian Bronner and Marc Mousli, to advance his research initiatives. These collaborations have played a vital role in enhancing the scope and impact of his work.
Conclusion
Raphaël Hopfner's contributions to cancer research through his patented innovations demonstrate his commitment to improving medical diagnostics and treatments. His work continues to inspire advancements in the field of oncology.